Post by Deleted on Jun 28, 2019 0:41:27 GMT
This is probably the first time I've opened a thread after being on this board for 6 years. In any case, I opened a position today in DTIL with some of my winnings from ARRY . If you follow or own CRISPR Therapeutics (CRSP) you might want to look at DTIL. It is a gene editing tool company that uses proprietary gene editing tools that are different from the CRISPR-associated protein 9 (Cas9) technology that CRSP is known for. The stock is highly speculative and only public a few months. But if you are on this board and own OPK then you are used to speculation (sadly in OPK's case). Do your own due diligence. Market cap is around $630 million and it is not being followed by many analysts at this point. Good luck!